CA9 and neoplasm: Bui et al reported low CA9 expression (defined as ≤ 85% of tumor cells) was an independent predictor of poor prognosis after nephrectomy [32] and Atkins et al reported CA9 expression was a predictor of responses to interleukin-2 therapy [31].